β-Lactam MICs Correlate Poorly with Mutant Prevention Concentrations for Clinical Isolates of Acinetobacter spp. and Pseudomonas aeruginosa

Gelijkaardige items

• Mutant Prevention Concentrations of Imipenem and Meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii
  door: Dahdouh, E., et al.
  Gepubliceerd in: (2014)
• Development of beta-lactam resistance and increased quinolone MICs during therapy of experimental Pseudomonas aeruginosa endocarditis.
  door: Bayer, A S, et al.
  Gepubliceerd in: (1988)
• Trends of Colistin MIC Among Acinetobacter Baumannii and Pseudomonas aeruginosa at a First-Class Hospital in Vietnam
  door: Tuan Huu Ngoc Nguyen, et al.
  Gepubliceerd in: (2025-01-01)
• Optimization of Meropenem Minimum Concentration/MIC Ratio To Suppress In Vitro Resistance of Pseudomonas aeruginosa
  door: Tam, Vincent H., et al.
  Gepubliceerd in: (2005)
• Rapid disc diffusion antibiotic susceptibility testing for Pseudomonas aeruginosa, Acinetobacter baumannii and Enterococcus spp.
  door: Hombach, Michael, et al.
  Gepubliceerd in: (2018)